Navigation Links
Bayer HealthCare to Sponsor World Federation of Hemophilia Global Training Program and Donate Kogenate® FS, Antihemophilic Factor (Recombinant), Commercially Valued At More Than $7 Million
Date:4/28/2011

ips have been awarded to hematologists, nurses, physiotherapists, laboratory scientists, orthopedic surgeons and dentists.  Since the program's founding, 400 fellows from 80 countries have received training.  Of note, more than 70% of fellows who have received training continue their career in hemophilia care.  

"More than 40 years after its founding, the IHTC program continues to improve the education of health care professionals who are dedicated to treating people with hemophilia," said Hansjoerg Duerr, Ph.D., Vice President, Specialty Medicine, Bayer HealthCare Pharmaceuticals.  "It is Bayer's privilege to sponsor an initiative of such great importance and also to make such a significant donation of Kogenate FS."

About Hemophilia A

Hemophilia A, also known as factor VIII deficiency or classic hemophilia, is largely an inherited bleeding disorder in which one of the proteins needed to form blood clots in the body is missing or reduced. Hemophilia A is the most common type of hemophilia and is characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. Approximately 400,000 people around the world have hemophilia.

About Kogenate® FS/KOGENATE® Bayer

Indications and Usage

Kogenate® FS, antihemophilic factor (recombinant) /KOGENATE® Bayer (recombinant coagulation Factor VIII [octocog alfa]) is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and perioperative management in adults and children (0-16 years) with hemophilia A. Kogenate® FS/KOGENATE® Bayer is also indicated for routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.

Important Safety Information

The most serious adverse reactions are systemic hypersensitivity reactions and th
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)...  Rhythm announced today the presentation of results from ... gastroparesis symptoms among diabetic patients in the U.S. than ... patients with both type 1 and type 2 diabetes, ... the more common type 2 disease. ... Professor of Medicine at Harvard Medical School and Director ...
(Date:5/20/2013)... With herbal medicines relied upon by consumers ... Pharmacopeial Convention (USP) will provide freely available public standards ... used in these products. Today, USP proposes the first ... Herbal Medicines Compendium ( HMC ) for comment ... . HMC will provide standards for ...
(Date:5/18/2013)... The Open Paradigm Project, in collaboration ... Psychiatry , and leading organizations in the movement ... media campaign showcasing video testimonials by individuals negatively ... on pathology and illness rather than wellness and ... Association,s (APA) rollout of its latest revision of ...
Breaking Medicine Technology:Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3
... 2, 2010 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Agency (MHRA) in the UK has completed review of the ... acceptance for BMN 673 for genetically-defined cancers.  The company expects ... of 2011. "BMN 673 has been proven to ...
... THOUSAND OAKS, Calif., Dec. 2, 2010 Amgen (Nasdaq: ... from several key Nplate® (romiplostim) studies at the 52nd Annual ... Dec. 4-7, 2010, in Orlando, Fla. Results from six studies ... purpura (ITP) add to the growing body of data supporting ...
Cached Medicine Technology:MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers 2MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers 3Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 2Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 3Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 4Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 5Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 6Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 7Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 8Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 9Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 10Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 11Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 12Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 13Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 14Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 15
(Date:5/20/2013)... Laptop radiation shield leader, DefenderPad, announced ... in the U.S., but has a growing demand in ... “With international sales continuing to expand, we’re now actively ... service the world markets,” a spokesman for DefenderPad said. ... , is the only laptop radiation shield ...
(Date:5/20/2013)... Wilmington, DE (PRWEB) May 20, 2013 Dr. ... Clear + Brilliant, a gentle fractional laser treatment clinically proven ... with the Clear + Brilliant are designed to ... , Clear + Brilliant can visibly illuminate skin tone, renew ... to the skin, and reduce the appearance of pores. Developed ...
(Date:5/20/2013)... 2013 At a time when the spotlight is focused ... of candy consumption is not associated with weight or certain ... in the April 30th issue of Nutrition Journal , ... no more likely to be overweight nor have greater risk ... a week) or even less frequent candy eaters (less than ...
(Date:5/20/2013)... HealthDay Reporter , , SUNDAY, May 19 (HealthDay ... of deep sleep by endlessly and subconsciously waking them ... small new study raises the possibility that it may ... disease. Don,t worry just yet if you ... possible that there may be no connection between the ...
(Date:5/20/2013)... 2013) Research presented at Digestive Disease Week (DDW) ... diarrhea (IBS-D) and hepatitis C. , An international ... In the phase II study, researchers found that the ... percent of the individuals treated. , "While there,s ... with constipation, we haven,t seen the same in IBS ...
Breaking Medicine News(10 mins):Health News:Laptop Radiation Shield Leader DefenderPad Expanding to International Markets 2Health News:Delaware Dermatologist Now Offers Clear + Brilliant Gentle Laser Skin Rejuvenation Treatments 2Health News:New study suggests candy consumption frequency not linked to obesity or heart disease 2Health News:New study suggests candy consumption frequency not linked to obesity or heart disease 3Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 2Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 3Health News:Pharmaceutical advances offer new options for health outcomes 2
... Dec. 2 ENERGYPARENTING(R) is a proven,antidote to the disorder-diagnosis-drug ... that upends existing parenting models by transforming,challenging children without the ... Current parenting models are failing American parents and resulting in ... control their behavior. , ...
... National Patient Registry which will make patients, medical records more ... and patients alike. , ... Los ... (CFS) has announced plans to streamline the medical industry,s billing ...
... Sun Shower(TM) brand just got,better with the addition of its ... Each flavor contains Lifeguard(TM) Protection, a fortification,package with powerful antioxidant ... the leading brands. , ... of Sun Shower(TM) Super,Blends iced coffees, teas and lattes," said ...
... the fourth,consecutive year, the Surf City USA(R) Marathon (Feb. 1, ... fundraising event that is directly,responsible for changing the lives of ... In the Fourth Annual "Run for Mobility", the event,s ... 5K as a way to raise funds,that sends specially engineered ...
... PATIENT-FOCUSED ORGANIZATION REACHES OUT TO EDUCATE CHICAGOANS , ... efforts to educate, inform, and empower the people of Chicago, ... 25-minute live call-in show, "Community Health," on Chicago Access ... on Channel 21. , , ...
... helps create empathy and improves attention to the scan, study ... a photo of the patient next to their radiological scans ... scans are read by radiologists, a new study finds. , ... interaction with the patient, putting a patient,s photo in his ...
Cached Medicine News:Health News:ENERGYPARENTING(R) is the Antidote to the ADHD/Ritalin Epidemic 2Health News:Medical-Billing.com to Revolutionize Electronic Medical Recordkeeping With National Patient Registry 2Health News:Medical-Billing.com to Revolutionize Electronic Medical Recordkeeping With National Patient Registry 3Health News:New Sun Shower(TM) Super Blends: Iced Coffees, Teas, Lattes With Half the Calories 2Health News:Surf City USA(R) Marathon Impacts the World 2Health News:The Gift of Health Caring at End of Life 2Health News:Patients' Photos Help Boost Radiologists' Accuracy 2
... 165 mm long blade. ... length 305 mm, 12.0 inches. ... right and left-hand cutting to ... inches (.89 mm). For thicker ...
5 mm small, sharp, protected blade. Angled at 105 degrees. Flat handle. Designated most popular model or size....
10 mm blade, angled left. Flat handle....
5 mm x 8 mm "D" shaped knife. Flat handle. Designated most popular model or size....
Medicine Products: